Status:

COMPLETED

The Efficacy of Thread Embedding Acupuncture on Pain Score, Neck Disability Index, and Pressure Pain Threshold for Myofascial Pain Therapy in the Upper Trapezius Muscle

Lead Sponsor:

Indonesia University

Conditions:

Myofascial Pain of Upper Trapezius Muscle

Eligibility:

All Genders

18-59 years

Phase:

NA

Brief Summary

Myofascial pain is characterized by myofascial trigger points, considered as a major cause of neck and shoulder pain in the working population. Thread-embedding acupuncture is a new acupuncture modali...

Detailed Description

This is a clinical trial study to evaluate and compare the effects of thread-embedding acupuncture and sham thread-embedding acupuncture as a therapy for myofascial pain in the upper trapezius muscle....

Eligibility Criteria

Inclusion

  • Male or female aged 18-59 years.
  • Subject with myofascial pain in the upper trapezius muscle.
  • VAS score of 30-70 mm from 100 mm during activities (everyday activities or light exercise).
  • Pain \> 3 months.
  • Willing to participate in this research to completion and sign informed consent.

Exclusion

  • Fibromyalgia.
  • Have had cervical spine surgery.
  • Have done Dry needling therapy on the upper trapezius muscle in the last 9 days
  • Have done thread acupuncture on the upper trapezius muscle in the last 6 months.
  • Have performed pharmacopuncture on the upper trapezius muscle in the last 6 months.
  • VAS score is more than 70 mm than 100 mm at resting.
  • History of anti-inflammatory drug treatment in the previous 2 weeks.
  • History of intra-articular steroid injections in the previous 3 months.
  • There is a tumor, wound, or skin infection at the needle insertion area.
  • Fever (≥ 37.5 oC).
  • There is a hypersensitivity reaction in previous acupuncture therapy (metal allergy, severe atopy, keloids, or other skin hypersensitivity).
  • Suffering from a blood disorder or taking blood thinners (anti-platelet or anti-coagulant drugs).
  • Have a heart condition or uncontrolled diabetes.
  • Blood glucose level (GDS) ≥200 mg/dL is checked by capillary blood using a glucometer.

Key Trial Info

Start Date :

August 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 31 2023

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT05987683

Start Date

August 21 2023

End Date

October 31 2023

Last Update

December 27 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Cipto Mangunkusumo Hospital

Jakarta, DKI Jakarta, Indonesia, 10430

2

Persahabatan Hospital

Jakarta, DKI Jakarta, Indonesia, 13230